Enhanced production by CIL reduces coal imports: Piyush Goyal

The government admits gap between demand and supply of coal cannot be bridged completely due to insufficient domestic availability of coking coal

GN Bureau | February 9, 2018


#PSU   #CIL   #Piyush Goyal  

Coal imports have fallen from 217.78 Mte in 2014-15 to 203.95 Mte in 2015-16 and further to 190.95 Mte in 2016-17. The trend of fall in import of coal has continued in the current fiscal.

As per the directorate general of commercial intelligence and statistics (DGCI&S), during April-October 2017-18, 118.86 Mte of coal was imported compared to 121.14 Mte in the corresponding period of the previous fiscal, showing a decline of 1.9 percent.

The government has said that the fall in coal imports is largely because of the enhanced production by Coal India Ltd. The vendible stock of CIL has increased from 53.47 Mt in 2015 to 68.42 Mt in 2017. The off-take /dispatch of coal of CIL has also increased from 488.86 Mt in 2014-15 to 543.16 Mt in 2016-17.

However, the government has admitted that the gap between demand and supply of coal cannot be bridged completely due to insufficient domestic availability of coking coal and power plants designed on imported coal will continue to import coal for their production.

The DGCI&S records show, a small quantity i.e. 1.07 MT of coal was imported (including coal, coke and briquettes) from USA in October, 2017 against 0.36 MT imported in January, 2015.

Minister of railways and coal Piyush Goyal gave this information in Lok Sabha.

 

Comments

 

Other News

BFSI Needs Military-grade Cybersecurity Solutions to Detect the Most Advanced Attacks: Deloitte

In such unprecedented times, businesses are facing different kinds of risk, which has

“New guidelines suppress digital, social media, and OTT platforms”

The government’s recent notification to regulate digital media is an attempt to suppress all social media platforms including digital news platforms, Dr. Shama Mohamed, Congress Spokesperson, has said. Only digital news platforms are able to say what they want to say, so the government

Covaxin Phase 3 clinical trial shows 81% efficacy

India’s first indigenously produced Covid-19 vaccine, Covaxin, has shown an interim efficacy of 81% in Phase III trials for preventing the virus. Covaxin has been developed in India jointly by the Indian Council of Medical Research (ICMR) along with Bharat Biotech International Limited (BBIL). &

In Mumbai, 29 private hospitals join vaccination drive

In order to expand the vaccination drive, the centre has allowed 29 private hospitals in Mumbai not empanelled in central and state health schemes to be designated as Covid Vaccination Centres (CVC). After a virtual meeting with the chief minister and the BMC commissioner Tuesday evening, th

Spectrum auction concludes; response better than expected

India on Tuesday concluded the spectrum auction after a total of six rounds of bidding. The authorities described the response as better than expected, with total bids valued at Rs 77,814.80 crore. The quality of service and customer experience is expected to improve with deployment of additional spectrum

Covid-19 has increased nutrition gap. Public feeding programmes need to be enhanced

One of the most significant setbacks from the massive upheaval caused by the Covid-19 pandemic is its effect on food and nutrition security. The pandemic has compounded the already rampant social inequity by adversely affecting the socio-economic status of millions of families across the nation. In the giv

Visionary Talk Series with Dr. Shama Mohamed On the present state of Governance



Archives

Current Issue

Opinion

Facebook    Twitter    Google Plus    Linkedin    Subscribe Newsletter

Twitter